Device
Deep Ensemble for the Recognition of Malignancy (DERM)
Deep Ensemble for the Recognition of Malignancy (DERM) is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Trials by Status
completed4100%
Recent Activity
Clinical Trials (4)
Showing 4 of 4 trials
NCT06654999
How Consistent is the Output of DERM, When Used to Assess Images of Potentially Cancerous Skin Lesions.
NCT05126173
DERM US and EU Validation Study
NCT04116983
DERM NMSC Validation Study
NCT04123678
DERM Health Economics Study
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4